The Safety and Efficacy of Low‐dose Tissue Plasminogen Activator in the Treatment of Systemic Sclerosis

E-ISSN： 1346-8138|22|9|637-642

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.22, Iss.9, 1995-09, pp. : 637-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Catheter‐Directed Low‐Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : e153-e158

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparative study between the efficacy of oral cimetidine and low‐dose systemic meglumine antimoniate (MA) with a standard dose of systemic MA in the treatment of cutaneous leishmaniasis

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 7, 2015-07 ,pp. : 834-838

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Oral Anticoagulant Therapy: Efficacy, Safety and the Low-Dose Controversy

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 2-3, 2000-01 ,pp. : 150-165

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Low-Dose Oral Immunotherapy for Hen's Egg Allergy in Children

International Archives of Allergy and Immunology, Vol. 171, Iss. 3-4, 2017-01 ,pp. : 265-268

Karger

Access to resources Recommend Favorite